Skip to main content
. Author manuscript; available in PMC: 2022 Oct 19.
Published in final edited form as: Am J Cardiol. 2018 Jun 2;122(5):768–774. doi: 10.1016/j.amjcard.2018.05.016

Table 1.

Characteristics of participants who reported ever taking a statin, overall, and by statin discontinuation status.

Characteristics Statin discontinuation
p-value
Overall
(n=7,216)
Yes
(n=1,081)
No
(n=6,135)

Age (years)
 < 65 997 (14%) 188 (17%) 809 (13%) <0.001
 65 – 74 3,442 (48%) 519 (48%) 2,923 (48%)
 ≥ 75 2,777 (39%) 374 (35%) 2,403 (39%)
Black 2,463 (34%) 355 (33%) 2,108 (34%) 0.33
Woman 3,840 (53%) 672 (62%) 3,168 (52%) <0.001
Residing in Stroke Belt/Buckle 4,073 (56%) 621 (58%) 3,452 (56%) 0.47
Less than high school education 491 (7%) 54 (5%) 437 (7%) 0.01
Current smoker* 509 (7%) 63 (6%) 446 (7%) 0.09
High perceived stress* 1,968 (28%) 296 (27%) 1,690 (28%) 0.88
Depressive symptoms* 763 (11%) 113 (11%) 650 (11%) 0.89
SF-12 physical component score*
 < 40 2,093 (31%) 357 (35%) 1,736 (30%) 0.01
 40–50 1,894 (28%) 266 (26%) 1,628 (28%)
 > 50 2,836 (41%) 409 (39%) 2,427 (42%)
SF-12 mental component score*
 < 50 1,060 (15%) 167 (16%) 893 (15%) 0.61
 50–60 4.078 (60%) 600 (58%) 3,478 (60%)
 > 60 1,685 (25%) 265 (26%) 1,420 (25%)
Low medication adherence* 2,135 (32%) 346 (35%) 1,789 (31%) 0.04
High blood pressure** 1,017 (14%) 165 (15%) 852 (14%) 0.23
Antihypertensive medication use* 3,874 (54%) 510 (47%) 3,364 (55%) <0.001
Diabetes mellitus* 2,165 (31%) 242 (22%) 1,923 (32%) <0.001
History of CVD* 2,214 (32%) 261 (25%) 1,953 (33%) <0.001
LDL-C (mg/dL)*
 < 100 4,267 (62%) 278 (27%) 3,989 (69%) <0.001
 100 – 129 1,491 (22%) 306 (30%) 1,185 (20%)
 ≥ 130 1,076 (16%) 432 (43%) 644 (11%)

Abbreviations –CVD, cardiovascular disease; LDL-C, low-density lipoprotein-cholesterol; SF-12, 12-item short form survey.

*

missing data for some participants

**

High blood pressure defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg.